These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8079589)

  • 1. [An efficacy study of the immunization of white mice with plague anti-idiotypic antibodies].
    Devdariani ZL; Korolev BV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):85-7. PubMed ID: 8079589
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant effect of anti-idiotypic antibodies to Yersinia pestis lipopolysaccharide.
    Feodorova VA; Devdariani ZL; Nazarova LS
    J Med Microbiol; 1999 Aug; 48(8):751-756. PubMed ID: 10450998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction 1-specific antibody response.
    Thomas RE; Simpson WJ; Perry LL; Schwan TG
    Am J Trop Med Hyg; 1992 Jul; 47(1):92-7. PubMed ID: 1386197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
    DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O
    Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of monoclonal antibodies for the production of a plague antibody erythrocyte diagnostic agent].
    Kanatov IuV; Levi MI; Shmuter MF; Men'shov PI; Temiralieva GA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):73-8. PubMed ID: 3904286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1].
    Ryzhko IV; Shcherbaniuk AI; Tsuraeva RI; Samokhodkina ED; Kasatkina IV; Tsetskhladze NS; Pasiukov VV; Roshchina NV
    Antibiot Khimioter; 1997; 42(1):12-6. PubMed ID: 9221699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological activity of the components of F1-antigen of Yersinia pestis].
    Kosse LV; Lebedeva SA; Cherniavskaia AS; Nekliaev VN; Markina OV; Morozova IV; Eremenko NS; Sal'nikova OI
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):76-81. PubMed ID: 16830596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
    Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
    Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The characteristics of the action of the capsular antigen of Yersinia pestis on cells from plague-susceptible and -insusceptible rodents].
    Kagramanov VS; Aseeva LE; Varivoda TIu
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):13-6. PubMed ID: 10851982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study by immunoblotting of the serological response in white mice and guinea pigs inoculated against plague].
    Nekliaev VN; Gamleshko KhP; Rozhkov KK
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):75-6. PubMed ID: 8553775
    [No Abstract]   [Full Text] [Related]  

  • 12. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.
    Li B; Jiang L; Song Q; Yang J; Chen Z; Guo Z; Zhou D; Du Z; Song Y; Wang J; Wang H; Yu S; Wang J; Yang R
    Infect Immun; 2005 Jun; 73(6):3734-9. PubMed ID: 15908403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains.
    Sabhnani L; Manocha M; Tomar D; Shashikiran D; Rao DN
    Int Immunopharmacol; 2003 Oct; 3(10-11):1413-8. PubMed ID: 12946437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies and cytokines independently protect against pneumonic plague.
    Kummer LW; Szaba FM; Parent MA; Adamovicz JJ; Hill J; Johnson LL; Smiley ST
    Vaccine; 2008 Dec; 26(52):6901-7. PubMed ID: 18926869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT; Eyles JE; Baillie LW; Keane-Myers AM
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):505-9. PubMed ID: 22515653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The activity of NK and K cells in mice vaccinated against plague].
    Solokhin EV; Pchelintsev SIu; Iurov SV; Uraeva VI; Afanas'ev SS; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):42-5. PubMed ID: 7992534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
    Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antibody spectrum after the inoculation of sensitive animals with Yersinia pestis and Yersinia pseudotuberculosis bacteria].
    Drobkov VI; Marakulin IV; Pogorel'skiĭ IP; Darmov IV; Smirnov EV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):81-5. PubMed ID: 8701667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.